PolyPid Ltd.

Infection Prevention

PolyPid is revolutionizing localized extended-release drug delivery to improve surgery outcomes.

PolyPid’s clinical-stage, PLEX (Polymer-Lipid Encapsulation matriX) technology delivers a controlled and continuous dose of medication to surgical sites, designed to better prevent infection, pain, and inflammation. PolyPid’s optimized therapeutic strategy ensures efficient treatment through proper localization, enhanced duration, and safe dosing.

SECTOR

Health Sciences

INVESTED

2016

STATUS

NASDAQ: PYPD (2020)

HQ

Petach Tikva, Israel

FOUNDERS

Amir Weisberg
Noam Emanuel Ph.D

Visit The Site

PolyPid Ltd.

Infection Prevention

SECTOR

INVESTED

STATUS

HQ

FOUNDERS

Subscribe to hear about Arc Ventures' updates and events.

Make the Connection.

ARC VENTURES